GI-MAP Roundtable Q&A with Dr Brady, Dr Jurgelewicz and Tony Hoffman
We think it is fair to say the GI-MAP has shaken up the diagnostic testing scene. The technology and methodology - while commonplace in microbiome research, and more recently in primary care for the identification of parasites and pathogens in the NHS - is revolutionising global healthcare diagnostics. We are proud to bring this test to the marketplace to enable clinicians the most specific and sensitive analysis available, for better patient outcomes.
However, naturally, with new technology, comes questions, queries, insecurities and we hear you! Many of you have been in touch with our technical support team, and we're so pleased that we have shaken a few feathers and prompted a deeper critical assessment of what's out there in terms of testing and technology... the scientific world never stands still, so neither should we!